(Q38176402)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24397349%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

title

Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24397349%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

main subject

extracellular matrix

0 references

hepatocellular carcinoma

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24397349%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Vinicio Carloni

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24397349%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Tu Vinh Luong

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24397349%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

publication date

12 February 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24397349%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24397349%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24397349%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24397349%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

834-843

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24397349%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

cites work

Global cancer statistics

1 reference

Global cancer statistics in the year 2000.

21 January 2018

1 reference

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

Fibrosis-dependent mechanisms of hepatocarcinogenesis

21 January 2018

1 reference

Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease

21 January 2018

1 reference

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

21 January 2018

1 reference

Trends in mortality from primary liver cancer in Europe

21 January 2018

1 reference

The changing pattern of epidemiology in hepatocellular carcinoma

21 January 2018

1 reference

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

21 January 2018

1 reference

Hepatocellular carcinoma--epidemiological trends and risk factors

21 January 2018

1 reference

The fibrotic microenvironment as a heterogeneity facet of hepatocellular carcinoma

21 January 2018

1 reference

Exploring genomic profiles of hepatocellular carcinoma.

21 January 2018

1 reference

Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets

21 January 2018

1 reference

Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma

21 January 2018

1 reference

Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

21 January 2018

1 reference

Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis

21 January 2018

1 reference

Systemic therapy for advanced hepatocellular carcinoma: a review.

21 January 2018

1 reference

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

21 January 2018

1 reference

Prognosis of hepatocellular carcinoma: the BCLC staging classification

21 January 2018

1 reference

Management of hepatocellular carcinoma

21 January 2018

1 reference

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

Cancer gene discovery in hepatocellular carcinoma

21 January 2018

1 reference

Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma

21 January 2018

1 reference

Evolution of the cancer genome

21 January 2018

1 reference

Current status of novel antifibrotic therapies in patients with chronic liver disease

21 January 2018

1 reference

Hepatocellular carcinoma pathogenesis: from genes to environment

21 January 2018

1 reference

Origin of myofibroblasts in liver fibrosis

21 January 2018

1 reference

What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis

21 January 2018

1 reference

Beauty is in the eye of the beholder: emerging concepts and pitfalls in hepatic stellate cell research

21 January 2018

1 reference

Myofibroblast - like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario.

21 January 2018

1 reference

21 January 2018

Liver fibrogenic cells

1 reference

Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts

21 January 2018

1 reference

Cellular basis of hepatic fibrosis and its role in inflammation and cancer

21 January 2018

1 reference

Tumor associated macrophages and neutrophils in tumor progression

21 January 2018

1 reference

Over-expression of the Endocan gene in endothelial cells from hepatocellular carcinoma is associated with angiogenesis and tumour invasion.

21 January 2018

1 reference

MiR-146a enhances angiogenic activity of endothelial cells in hepatocellular carcinoma by promoting PDGFRA expression

21 January 2018

1 reference

Targeting heat-shock protein 90 improves efficacy of rapamycin in a model of hepatocellular carcinoma in mice

21 January 2018

1 reference

Hepatocellular carcinoma biology

21 January 2018

1 reference

The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets.

21 January 2018

1 reference

Role of the microenvironment in hepatocellular carcinoma development and progression

21 January 2018

1 reference

Mechanical signaling through the cytoskeleton regulates cell proliferation by coordinated focal adhesion and Rho GTPase signaling.

21 January 2018

1 reference

Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells

21 January 2018

1 reference

Mechanical stiffness of liver tissues in relation to integrin β1 expression may influence the development of hepatic cirrhosis and hepatocellular carcinoma

21 January 2018

1 reference

Quantum dots-based in situ molecular imaging of dynamic changes of collagen IV during cancer invasion

21 January 2018

1 reference

Mouse models of hepatocellular carcinoma

21 January 2018

1 reference

Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma

21 January 2018

1 reference

Extracellular matrix dynamics in hepatocarcinogenesis: a comparative proteomics study of PDGFC transgenic and Pten null mouse models

21 January 2018

1 reference

Serum markers detect the presence of liver fibrosis: a cohort study.

21 January 2018

1 reference

Role of extracellular membrane vesicles in intercellular communication of the tumour microenvironment.

21 January 2018

1 reference

Matricellular proteins: a sticky affair with cancers

21 January 2018

1 reference

Matricellular proteins: priming the tumour microenvironment for cancer development and metastasis

21 January 2018

1 reference

History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells

21 January 2018

1 reference

Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver

21 January 2018

1 reference

Update on the pathophysiology of liver fibrosis

21 January 2018

1 reference

Evolving therapies for liver fibrosis

21 January 2018

1 reference

21 January 2018

1 reference

Fibrogenic signalling in hepatic stellate cells.

21 January 2018

1 reference

Liver fibrosis: from the bench to clinical targets

21 January 2018

1 reference

Mechanisms of nitric oxide interplay with Rho GTPase family members in modulation of actin membrane dynamics in pericytes and fibroblasts

21 January 2018

1 reference

Hepatocyte-stellate cell cross-talk in the liver engenders a permissive inflammatory microenvironment that drives progression in hepatocellular carcinoma

21 January 2018

1 reference

Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge

21 January 2018

1 reference

Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma

21 January 2018

1 reference

Emerging signaling pathways in hepatocellular carcinoma.

21 January 2018

1 reference

Hypoxia, angiogenesis and liver fibrogenesis in the progression of chronic liver diseases

21 January 2018

1 reference

Myristoylated Alanine-Rich protein Kinase C Substrate (MARCKS) expression modulates the metastatic phenotype in human and murine colon carcinoma in vitro and in vivo

21 January 2018

1 reference

Role of the stromal-derived factor-1 (SDF-1)-CXCR4 axis in the interaction between hepatic stellate cells and cholangiocarcinoma

21 January 2018

1 reference

Discoidin domain receptor 2 deficiency predisposes hepatic tissue to colon carcinoma metastasis

21 January 2018

1 reference

Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes

21 January 2018

1 reference

A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture

21 January 2018

1 reference

Experimental liver fibrosis research: update on animal models, legal issues and translational aspects

21 January 2018

1 reference

Gene expression profiles during hepatic stellate cell activation in culture and in vivo

21 January 2018

1 reference

Overexpression of c-myc in hepatocytes promotes activation of hepatic stellate cells and facilitates the onset of liver fibrosis

21 January 2018

1 reference

Snail1 transcription factor is a critical mediator of hepatic stellate cell activation following hepatic injury.

21 January 2018

1 reference

Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis

21 January 2018

1 reference

Increased contractility of hepatic stellate cells in cirrhosis is mediated by enhanced Ca2+-dependent and Ca2+-sensitization pathways.

21 January 2018

1 reference

Hepatic stellate cells and the reversal of fibrosis

21 January 2018

1 reference

21 January 2018

1 reference

Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors

21 January 2018

1 reference

Deactivation of hepatic stellate cells during liver fibrosis resolution in mice.

21 January 2018

1 reference

Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis

21 January 2018

1 reference

Anti-fibrotic therapy: lost in translation?

21 January 2018

1 reference

Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype

21 January 2018

1 reference

Matricellular protein CCN1 promotes regression of liver fibrosis through induction of cellular senescence in hepatic myofibroblasts.

21 January 2018

1 reference

Senescence of activated stellate cells limits liver fibrosis

21 January 2018

1 reference

Granule exocytosis mediates immune surveillance of senescent cells.

21 January 2018

1 reference

Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome

21 January 2018

1 reference

Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B

21 January 2018

1 reference

Facing the dawn of immunotherapy for hepatocellular carcinoma

21 January 2018

1 reference